(IN BRIEF) Fresenius Kabi, an operating company of Fresenius, has announced that the U.S. FDA has approved a rituximab biosimilar developed by Dr. Reddy’s Laboratories for the U.S. market. Under an exclusive commercialisation agreement, Fresenius Kabi holds the U.S. commercialisation … Read the full press release
Posted in Business, Germany, Government, Healthcare, Pharma & Biotech, Science
Tagged #FutureFresenius, affordable biologic therapies, analytical data, autoimmune diseases, B cells, B lymphocytes, B-cell malignancies, Bad Homburg v. d. Höhe, biologic medicines, biopharma, biopharmaceuticals, Biosimilar, biosimilars portfolio, CD20 antigen, chronic lymphocytic leukemia, clinical data, clinical nutrition, Dr. Eduard Fresenius, Dr. Reddy’s, Dr. Reddy’s Laboratories, Dr. Sang-Jin Pak, Else Kröner, Else Kröner Fresenius Foundation, exclusive commercialisation agreement, FDA, FDA approval, FDA Approves Dr. Reddy’s Rituximab Biosimilar for U.S. Commercialisation by Fresenius Kabi, Fresenius, Fresenius Helios, Fresenius Kabi, Fresenius Kabi Announces FDA Approval of Rituximab Biosimilar for U.S. Market, Fresenius Kabi Strengthens U.S. Biosimilars Portfolio With Rituximab Approval, Fresenius Medical Care, Fresenius SE & Co KGaA, Genentech, Germany, GPA, granulomatosis with polyangiitis, hematologic malignancies, immunology, intravenous generic drugs, medical technology, microscopic polyangiitis, monoclonal antibody, MPA, Nicole Meier, non-clinical data, Non-Hodgkin lymphoma, oncology, patient access, pharmacokinetic studies, rheumatoid arthritis, Rituxan, rituximab, rituximab biosimilar, totality of the evidence, U.S. Food and Drug Administration, U.S. market
(IN BRIEF) Fresenius has launched the Pedismof® range in Europe, a new ready-to-use three-chamber bag solution for pediatric parenteral nutrition developed by Fresenius Kabi. The range provides age-specific formulations for preterm and term neonates, infants, children and adolescents, supporting standardized … Read the full press release
Posted in Business, European Union, Germany, Healthcare, Management, Pharma & Biotech, Science, Technology
Tagged #FutureFresenius, adolescents, amino acids, Bad Homburg, CHILDREN, chronically ill patients, clinical nutrition, critically ill patients, Dr Marc Alexander Mahl, Dr Michael Moser, essential therapies, European pediatric nutrition guidelines, Fish oil, Fresenius, Fresenius Helios, Fresenius Kabi, Fresenius Kabi Introduces Ready-to-Use Three-Chamber Bag Solution for Pediatric Nutrition in Europe, Fresenius Launches Pedismof Range in Europe to Expand Pediatric Parenteral Nutrition Portfolio, Fresenius Launches Pedismof Range in Europe to Support Pediatric Parenteral Nutrition, Fresenius SE & Co KGaA, Fresenius Strengthens Clinical Nutrition Offering with European Launch of Pedismof Range, Germany, glucose, healthcare professionals, Infants, Innovation Center, lifesaving medicines, lipid emulsion, Medical Technologies, Michael Sen, neonatal nutrition, Nicole Meier, omega-3 fatty acids, patient-centered innovation, pediatric nutrition, pediatric parenteral nutrition, Pedismof, Pierluigi Antonelli, preterm neonates, ready-to-use nutrition solution, Rejuvenate, Robert Möller, Sara Hennicken, SMOFlipid, standardized nutrition care, term neonates, three-chamber bag, Wolfgang Kirsch
(IN BRIEF) Fresenius has announced a strategic investment in Avelios Medical in collaboration with SAP, further advancing their partnership to create a digital, AI-enabled healthcare ecosystem in Europe. The initiative focuses on developing a next-generation, cloud-based hospital information system that … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Science, Technology
Tagged AI in healthcare, Avelios Medical, Christian Albrecht, Christian Pawlu, cloud-native platforms, data sovereignty, digital healthcare, European healthcare systems, Fresenius, Fresenius and SAP Collaborate on Next Generation Hospital Systems with New Avelios Medical Partnership, health tech innovation, healthcare digitalisation, hospital information systems, interoperability, SAP, Strategic Investment in Avelios Medical Advances Fresenius and SAP Vision for Digital Healthcare in Europe
(IN BRIEF) Fresenius and SAP have announced plans to form a strategic partnership to accelerate digital innovation in healthcare and establish a sovereign, interoperable, and AI-supported healthcare ecosystem. By combining Fresenius’ global healthcare expertise with SAP’s digital platforms and AI … Read the full press release
Posted in Artificial Intelligence (AI), Business, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI in healthcare, AnyEMR, Christian Klein, data sovereignty, digital healthcare, digital transformation, electronic medical records, European healthcare innovation, Fresenius, HL7 FHIR, hospital information systems, interoperable healthcare systems, Michael Sen, SAP, SAP Business AI, SAP Business Data Cloud, SAP Business Suite, SAP Business Technology Platform, Strategic Fresenius–SAP Collaboration Targets AI-Supported Healthcare Transformation, strategic partnership
(IN BRIEF) Fresenius’ mAbxience has partnered with HP Inc. to co-develop an AI and digital-twin solution that can model and optimise biopharmaceutical manufacturing. The technology uses real plant data to simulate production scenarios, helping increase reliability, stabilise yields and shorten … Read the full press release
Posted in Artificial Intelligence (AI), Business, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI collaboration, AI Collaboration Between mAbxience and HP Targets Smarter, Biopharma Innovation, bioprocess optimisation, biosimilars production, cell culture process, digital transformation, digital twin biomanufacturing, Fresenius, FutureFresenius strategy, HP Inc., industrial AI, León Spain, mAbxience, manufacturing efficiency, monoclonal antibodies, More Predictable Bioprocessing
(IN BRIEF) The European Commission has approved Fresenius Kabi’s denosumab biosimilars, Conexxence® and Bomyntra®, for all uses of the originator product. These include osteoporosis treatment for postmenopausal women and at-risk men, mitigation of treatment-related bone loss, prevention of skeletal complications … Read the full press release
Posted in Business, Environment, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged #FutureFresenius, Biopharma platform, Bomyntra, cancer metastasis to bone, Conexxence, denosumab biosimilar, Europe, European Commission approval, Fresenius, Fresenius Kabi, Fresenius Kabi Deutschland GmbH, giant cell tumor of bone, high-quality biosimilars, osteoporosis, postmenopausal women, registered trademarks, skeletal complications, treatment-related bone loss
(IN BRIEF) Fresenius has signed a five-year global contract with Microsoft to enhance IT collaboration and security for its global workforce. Beginning in June 2025, the agreement will include tools such as Microsoft Defender, Microsoft 365, SharePoint, OneDrive, and Microsoft … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Science, Security & Safety, Technology
Tagged AI enablement, Chief Information Officer, cloud computing, cloud migration, collaboration, data protection, Digital Ecosystem, Fresenius, global contract, Helios Group, Ingo Elfering, IT framework, IT security, Michael Sahnau, Microsoft, Microsoft 365, Microsoft Defender, Microsoft Germany, Microsoft Power BI, OneDrive, partnership, SECURITY, SharePoint
(IN BRIEF) At the Annual General Meeting in Frankfurt am Main, shareholders of Fresenius SE & Co. KGaA overwhelmingly approved proposals from the General Partner and the Supervisory Board. Chairman of the Supervisory Board, Wolfgang Kirsch, commended Fresenius’ resilience amidst … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged #FutureFresenius Agenda, AGM, Financial, Fresenius, investment, Michael Sen, Wolfgang Kirsch
(IN BRIEF) Fresenius Management SE has extended Sara Hennicken’s term as Chief Financial Officer (CFO) until 2027, two years earlier than planned, to ensure continuity in advancing the #FutureFresenius strategy. Hennicken, who joined Fresenius in 2019, has been instrumental in … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Management, Pharma & Biotech, Technology
Tagged #FutureFresenius, CFO, Chief Financial Officer, Deutsche Bank, finance, Fresenius, Fresenius Helios, Fresenius Kabi, Fresenius Management SE, Fresenius Medical Care, Sara Hennicken, Supervisory Board, transparency, Wolfgang Kirsch
(IN BRIEF) Fresenius had a strong finish in 2023, with a robust fourth quarter performance. They project accelerated earnings growth in 2024 due to the momentum from their #FutureFresenius initiatives. Achieving their raised outlook for FY/23, the company saw continued … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?